ES2012129A6 - Un metodo para la obtencion de fragmentos de cd4 humana biologicamenteactivos. - Google Patents

Un metodo para la obtencion de fragmentos de cd4 humana biologicamenteactivos.

Info

Publication number
ES2012129A6
ES2012129A6 ES8803064A ES8803064A ES2012129A6 ES 2012129 A6 ES2012129 A6 ES 2012129A6 ES 8803064 A ES8803064 A ES 8803064A ES 8803064 A ES8803064 A ES 8803064A ES 2012129 A6 ES2012129 A6 ES 2012129A6
Authority
ES
Spain
Prior art keywords
fragments
biologically active
recombinant plasmid
active human
obtaining biologically
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES8803064A
Other languages
English (en)
Inventor
Ellis Reinherz
Rebecca Hussey
Joseph Sodroski
Neil Richardson
Linda K Clayton
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dana Farber Cancer Institute Inc
Original Assignee
Dana Farber Cancer Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US07/217,475 external-priority patent/US5109123A/en
Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc
Publication of ES2012129A6 publication Critical patent/ES2012129A6/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70514—CD4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

UN METODO PARA LA OBTENCION DE FRAGMENTOS DE CD4 HUMANA BIOLOGICAMENTE ACTIVOS, CARACTERIZADO PORQUE COMPRENDE LAS ETAPAS DE: A) CONSTRUIR UN PLASMIDO RECOMBINANTE QUE PRODUCE CD4 HUMANA SOLUBLE; B) CONTRASFECTAR EL DNA PLASMIDO RECOMBINANTE CON DNA DE VIRUS DE POLIHEDROSIS NUCLEAR AUTOGRAPHA CALIFORNICA (ACNPV) EN CELULAS DE SPODOPTERA FRUGIPERDA (SF9), LO CUAL SE TRADUCE EN LA RECOMBINACION ENTRE LA SECUENCIA RECOMBINANTE DEL PLASMIDO RECOMBINANTE Y LA SECUENCIA GENETICA DE POLIHEDRINA DE ACNPV; C) SELECCIONAR PLACAS NEGATIVAS A LA OCLUSION; D) CULTIVAR LAS PLACAS NEGATIVAS A LA OCLUSION; Y E) RECOGER EL POLIPEPTIDO PRECIPITADO.
ES8803064A 1987-10-08 1988-10-07 Un metodo para la obtencion de fragmentos de cd4 humana biologicamenteactivos. Expired - Lifetime ES2012129A6 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US10618587A 1987-10-08 1987-10-08
US14431388A 1988-01-14 1988-01-14
US20658588A 1988-06-14 1988-06-14
US07/217,475 US5109123A (en) 1988-06-14 1988-07-11 Alteration of ability of soluble CD4 fragments to bind HIV

Publications (1)

Publication Number Publication Date
ES2012129A6 true ES2012129A6 (es) 1990-03-01

Family

ID=27493499

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8803064A Expired - Lifetime ES2012129A6 (es) 1987-10-08 1988-10-07 Un metodo para la obtencion de fragmentos de cd4 humana biologicamenteactivos.

Country Status (9)

Country Link
EP (1) EP0400010A1 (es)
JP (1) JPH03504234A (es)
AU (1) AU2614888A (es)
DK (1) DK87490A (es)
ES (1) ES2012129A6 (es)
GR (1) GR1000850B (es)
IL (1) IL87902A0 (es)
NZ (1) NZ226475A (es)
WO (1) WO1989003222A1 (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637677A (en) 1987-07-16 1997-06-10 The Trustees Of The University Of Pennsylvania Biologically active compounds and methods of constructing and using the same
ZA887365B (en) * 1987-10-02 1990-05-30 Genentech Inc Adheson variants
AU623924B2 (en) * 1988-07-22 1992-05-28 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Cytotoxic agent against specific virus infection
US5206353A (en) * 1988-07-23 1993-04-27 The United States Of America As Represented By The Department Of Health And Human Services CD-4/cytotoxic gene fusions
EP0408372A1 (en) * 1989-07-13 1991-01-16 Smithkline Beecham Corporation Anti-viral therapy
KR927003613A (ko) * 1989-08-23 1992-12-18 더 제너랄 호스피탈 코오퍼레이숀 비-인체 영장동물의 cd4폴리텝타이드, 글리코실화할 수 있는 인체 cd4분자, 그것의 단편, 그것의 융합 단백질, 유전자 서열 및 그것의 용도
US5614612A (en) * 1990-03-09 1997-03-25 Haigwood; Nancy L. Purified gp120 compositions retaining natural conformation
JPH0725794B2 (ja) * 1990-03-23 1995-03-22 呉羽化学工業株式会社 新規なペプチド
WO1992004914A1 (en) * 1990-09-14 1992-04-02 The Trustees Of The University Of Pennsylvania Design of bioactive peptides based on immunoglobulin structure
JP3670276B2 (ja) 1991-02-08 2005-07-13 プロゲニクス・ファーマスーティカルズ、インコーポレイテッド ＣＤ４― ガンマ・２キメラ及びＣＤ４ ― ＩｇＧ２・キメラ
US7070991B2 (en) 1991-02-08 2006-07-04 Progenics Pharmaceuticals, Inc. Cells expressing a CD4-IgG2 chimeric heterotetramer
AU1438592A (en) * 1991-02-08 1992-09-07 Progenics Pharmaceuticals, Inc. Cd4-gamma1 and cd4-igg1 chimeras
US5234905A (en) * 1991-02-22 1993-08-10 University Of Colorado Foundation, Inc. Soluble CD4 molecules modified to prolong circulating half-life
EP0510483A1 (en) * 1991-04-22 1992-10-28 Boehringer Ingelheim Pharmaceuticals Inc. Method for the detection of viruses
JP4776075B2 (ja) 1998-12-31 2011-09-21 ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド 改変ｈｉｖｅｎｖポリペプチド
AU2221600A (en) 1998-12-31 2000-07-31 Chiron Corporation Improved expression of hiv polypeptides and production of virus-like particles
AU2487300A (en) 1998-12-31 2000-07-31 Chiron Corporation Polynucleotides encoding antigenic hiv type c polypeptides, polypeptides and uses thereof
US7935805B1 (en) 1998-12-31 2011-05-03 Novartis Vaccines & Diagnostics, Inc Polynucleotides encoding antigenic HIV Type C polypeptides, polypeptides and uses thereof
EP1411770A4 (en) 2001-07-05 2006-05-10 Chiron Corp POLYNUCLEOTIDES CODING FOR ANTIGENIC C-TYPE HIV POLYPEPTIDES, POLYPEPTIDES AND THEIR USE
US20030170614A1 (en) 2001-08-31 2003-09-11 Megede Jan Zur Polynucleotides encoding antigenic HIV type B polypeptides, polypeptides and uses thereof
CA2458995C (en) 2001-08-31 2013-04-30 Chiron Corporation Polynucleotides encoding antigenic hiv type b polypeptides, polypeptides and uses thereof
EP2968453B1 (en) 2013-03-15 2019-12-04 The U.S.A. as represented by the Secretary, Department of Health and Human Services Stabilized single human cd4 domains and fusion proteins
WO2017055522A1 (en) 2015-09-29 2017-04-06 Academisch Medisch Centrum Stabilized env proteins of hiv

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3751751T2 (de) * 1986-08-21 1996-10-17 Univ Columbia Für das t-zell oberflächenprotein t4 kodierende dna und verwendung von t4-fragmenten bei der behandlung von aids
PT88641B (pt) * 1987-10-02 1993-04-30 Genentech Inc Metodo para a preparacao de uma variante de adesao

Also Published As

Publication number Publication date
AU2614888A (en) 1989-05-02
GR1000850B (el) 1993-02-17
NZ226475A (en) 1991-03-26
EP0400010A1 (en) 1990-12-05
IL87902A0 (en) 1989-03-31
DK87490D0 (da) 1990-04-06
JPH03504234A (ja) 1991-09-19
DK87490A (da) 1990-06-08
WO1989003222A1 (en) 1989-04-20

Similar Documents

Publication Publication Date Title
ES2012129A6 (es) Un metodo para la obtencion de fragmentos de cd4 humana biologicamenteactivos.
Gray et al. On understanding the organisation of the retinal receptor synapses
Anderson A cytological study of Chilomonas paramecium with particular reference to the so‐called trichocysts
CO4820445A1 (es) Expresion de proteina en sistemas de expresion del vector baculovirus
Momen Taxonomy of Trypanosoma cruzi: a commentary on characterization and nomenclature
KR890002404A (ko) 안정하고 생존가능한 재조합 동물 세포 바이러스 벡터의 제조방법
CA2295858A1 (en) Rhabdoviruses with reengineered coats
SE8504872D0 (sv) Selekteringsforfarande och medel herfor
PE65198A1 (es) Virosomas cationicos como sistema de transferencia para material genetico
UY24367A1 (es) Vacunas contra tumores y procedimiento para su produccion
ES8504255A1 (es) Procedimiento para la produccion de una hormona de crecimiento de porcino.
IL80612A0 (en) Method of producing peptides
Aitchison et al. Duplication of the flagellar apparatus and cytoskeletal microtubule system in the alga Polytomella
EP0390757A3 (en) Lens for traffic lights and method of making same
Norstog Fine structure of the spermatozoid of Zamia: the Vierergruppe
Faull The cytology of Laboulbenia chaetophora and L. gyrinidarum
Hopson On the generic separation of the ornithischian dinosaurs Lychorhinus and Heterodontosaurus from the Stormberg series (upper Triassic) of South Africa
O'Kelly et al. Ultrastructure and Phylogenetic Relationships of Chaetopeltidales Ord. Nov.(Chlorophyta, Chlorophyceae) 1
EP0330367A3 (en) Digital to analogue convertors
Hedley et al. Adhesion plaques associated with the production of a daughter cell in Euglypha (Testacea; Potozoa)
ES2061850T3 (es) Virus recombinante de la enfermedad de marek, su procedimiento de preparacion y vacuna.
ES2065915T3 (es) Procedimiento para aumentar la expresion de polipeptidos en un cultivo de celula recombinante.
Borghese et al. Acinar ultrastructure of the submandibular gland of Mus musculus during embryonic development
Gao et al. The taxonomy and ultrastructure of a marine dinoflagellate, Scrippsiella minima sp. nov.
Honigberg et al. Fine structure of Trichomitus batrachorum (Perty)

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2008-10-07